Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An accessory pathway is an aberrant bundle of myocardial tissue that forms an abnormal electrical connection between atrial and ventricular chambers of the heart, bypassing the normal atrioventricular node. This results from incomplete insulation of atrial from ventricular myocardium during embryological development. Accessory pathways allow electrical impulses to circumvent physiological conduction delay, which can cause various arrhythmias, including atrioventricular re-entrant tachycardia and pre-excitation syndromes such as Wolff–Parkinson–White syndrome. Accessory pathways are classified by their anatomical location, conduction direction (anterograde, retrograde, or bidirectional), and conduction properties (decremental or non-decremental). They are not molecular targets but rather pathological substrates for arrhythmia and are treated by ablative procedures or antiarrhythmic drugs that modulate cardiac conduction.
Slowing conduction through the accessory pathway or AV node, terminating arrhythmia circuits, suppressing conduction velocity in cardiac tissue
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Accessory pathway (AP).